REXULTI® (brexpiprazole) agitation that may happen with dementia due to Alzheimer's disease

Discover the only FDA-Approved treatment for agitation that may happen with dementia due to Alzheimer’s disease. See Important Safety Info and Full Prescribing Info, including Boxed WARNING.

FDA rushes approval of dementia drug that quadruples risk of death

First FDA Approved Medication for Agitation Associated with Alzheimer's Dementia – Psychiatry Education Forum

FDA Approves Rexulti for Treating Agitation Due to Alzheimer's - MyChesCo

Otsuka and Lundbeck Issue Statement on REXULTI for Alzheimer's

What is agitation that may happen with dementia due to Alzheimer's disease?

Brexpiprazole Demonstrates Clinically Meaningful Improvements for Agitation Due to Alzheimer Disease

Pyrls on Instagram: Brexpiprazole's (REXULTI) new indication makes it the first FDA-approved option for agitation associated with dementia due to Alzheimer's disease ✨ Learn more about brexpiprazole in your Pyrls app or

JAMA Neurology Publishes Complete Results of Positive Phase 3 Study of REXULTI® (brexpiprazole) for Agitation Associated with Dementia Due to Alzheimer's Disease

Decision on Brexpiprazole for Alzheimer's Agitation Due in May

This Month in Psychopharmacology

FDA Approves First Drug to Treat Agitation Symptoms Associated with Dementia due to Alzheimer's Disease - US FDA

FDA Approves the First Drug for Alzheimer's Agitation: Rexulti

FDA approves supplemental new drug application for Rexulti to treat Alzheimer's agitation